Novartis Ag (NVS) Debt to Equity (2015 - 2025)
Novartis Ag's (NVS) quarterly Debt to Equity came in at $0.62 in Q4 2025, up 24.87% year-on-year from $0.5 in Q4 2024, and up 24.87% quarter-over-quarter from $0.5 in Q4 2024.
Novartis Ag (NVS) Debt to Equity (2015 - 2025) Analysis & Trends
Novartis Ag has disclosed Debt to Equity across 11 years of filings, most recently posting $0.62 for Q4 2025.
- Debt to Equity for Q4 2025 came in at $0.62, up 24.87% year-over-year; the trailing twelve-month figure through Dec 2025 was $0.62 (up 24.87% YoY), and the FY2025 annual result was $0.62, up 24.87% from the prior year.
- Debt to Equity came in at $0.62 for Q4 2025 at Novartis Ag, up from $0.5 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.62 in Q4 2025 to a low of $0.41 in Q4 2023.
- The 5-year median for Debt to Equity is $0.44 (2022), against an average of $0.48.
- Across the five-year window, Debt to Equity soared 102.14% in 2021 and decreased 7.44% in 2023, its largest moves.
- Novartis Ag's Debt to Equity stood at $0.43 in 2021, then climbed by 2.32% to $0.44 in 2022, then declined by 7.44% to $0.41 in 2023, then gained by 22.33% to $0.5 in 2024, then gained by 24.87% to $0.62 in 2025.
- The last three Debt to Equity figures came in at $0.62 (Q4 2025), $0.5 (Q4 2024), and $0.41 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 1.39 |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 0.68 |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | -9.70 |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 1.07 |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 6.24 |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 0.94 |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 0.72 |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 2.22 |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.62 |
| Dec 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.41 |
| Dec 31, 2022 | 0.44 |
| Dec 31, 2021 | 0.43 |
| Dec 31, 2020 | -20.11 |
| Dec 31, 2019 | -4.52 |
| Dec 31, 2018 | -335.81 |
| Dec 31, 2017 | 405.36 |
| Dec 31, 2016 | 0.32 |
| Dec 31, 2015 | 0.00 |